Yarrow Bioscience
YARW
86 hedge funds and large institutions have $92.7M invested in Yarrow Bioscience in 2020 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 9 closing their positions.
433% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 9
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
79% more funds holding
Funds holding: 48 → 86 (+38)
44% more capital invested
Capital invested by funds: $64.3M → $92.7M (+$28.4M)
32.35% less ownership
Funds ownership: 57.8% → 25.45% (-32%)
40% less call options, than puts
Call options by funds: $167K | Put options by funds: $277K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$28.9M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$16.8M |
| 3 |
DA
DSC Advisors
Chicago,
Illinois
|
+$9.05M |
| 4 |
BlackRock
New York
|
+$8.74M |
| 5 |
6CM
683 Capital Management
New York
|
+$8.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$10.1M |
| 2 |
Janus Henderson Group
London,
|
-$5.94M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$3.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.25M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.4M |
YARW Hedge Fund Activity: Q1 2020 in Review
86 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience (YARW) for Q1 2020, worth a combined $92.7M — up 44% from $64.3M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new YARW positions and 9 closed out — a net gain of 39 holders — while 24 added to existing stakes and 8 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $28.9M. The largest seller was First Manhattan, exiting entirely with an estimated $10.1M sold.
- 86 institutional investors held Yarrow Bioscience (YARW) as of Q1 2020, up from 48 in Q4 2019.
- Funds reported $92.7M of Yarrow Bioscience stock for Q1 2020, up 44% quarter-over-quarter.
- 48 funds opened new Yarrow Bioscience positions in Q1 2020 and 9 closed out, a net change of +39 holders.
- The largest Yarrow Bioscience buyer in Q1 2020 was Perceptive Advisors, an estimated $28.9M added.
- The largest Yarrow Bioscience seller in Q1 2020 was First Manhattan, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2020.